| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-PCDH7-6:1 | GGCUGGAGUGUAGUGGUACGAUCUUGGCUUACUGCAACCUCCACCUCCU… | 605 nt | 0.3471 |
| lnc-PCDH7-6:2 | GGCUGGAGUGUAGUGGUACGAUCUUGGCUUACUGCAACCUCCACCUCCU… | 690 nt | 0.3768 |
| lnc-PCDH7-6:3 | AGGCUGGAGUGUAGUGGUACGAUCUUGGCUUACUGCAACCUCCACCUCC… | 1990 nt | 0.3211 |
| lnc-PCDH7-6:4 | AGGCUGGAGUGUAGUGGUACGAUCUUGGCUUACUGCAACCUCCACCUCC… | 289 nt | 0.4394 |
| lnc-PCDH7-6:5 | CCAGGAUUACAGACUUCUUUUAGCAUAUACAGAGAAGCCACAUGAAAGU… | 5134 nt | 0.3555 |
| lnc-PCDH7-6:6 | CCAGGAUUACAGACUUCUUUUAGCAUAUACAGAGAAGCCACAUGAAAGU… | 5097 nt | 0.3086 |
No relevant information is available at the moment.
A study in human patients identified LINC02506 as a long non-coding RNA that is upregulated in heart failure compared to myocardial fibrosis, suggesting a mechanistic role in disease progression [Wang et al. DOI:10.3389/fcvm.2021.664044].